Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IA/Cedar Rapids
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Cedar Rapids, IA

Studies commonly pay $75 to $4,500 per completed study

595 clinical trials are currently recruiting participants within 30 miles of Cedar Rapids. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

595studies recruiting
2+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Cedar Rapids right now

Top 25 of 595 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi) · Sponsor: National Cancer Institute (NCI)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
University of Iowa-Holden Comprehensive Cancer Center ( Site 0139) — Iowa City, Iowa (22.4 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma, Relapsed/Refractory Multiple Myeloma Phase 2 Interventional 100 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi) · Sponsor: C4 Therapeutics, Inc.

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

Endometrial Endometrioid Adenocarcinoma, Endometrial Hyperplasia Phase 2 Interventional 140 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi) · Sponsor: New Mexico Cancer Research Alliance

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Physicians' Clinic of Iowa PC — Cedar Rapids, Iowa (3.4 mi) · Sponsor: SWOG Cancer Research Network

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 Phase 1, Phase 2 Interventional 10 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi) · Sponsor: AskBio Inc

The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies

Adverse Childhood Experiences, Vascular Dilatation N/A Interventional 70 participants sought
Integrative Laboratory of Applied Physiology and Lifestyle Medicine — Iowa City, Iowa (22.4 mi) · Sponsor: Nathaniel Jenkins

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi) · Sponsor: Hoffmann-La Roche

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Iowa City, Iowa (22.4 mi) · Sponsor: Sameek Roychowdhury

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Colo-rectal Cancer Phase 2 Interventional 79 participants sought
University of Iowa - Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi) · Sponsor: NSABP Foundation Inc

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Bladder Cancer, Recurrent Bladder Cancer N/A Observational 408 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi) · Sponsor: University of Washington

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
University of Iowa Health Care. ( Site 0017) — Iowa City, Iowa (22.4 mi) · Sponsor: Merck Sharp & Dohme LLC

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

Recurrent Acute Pancreatitis Phase 2 Interventional 60 participants sought
University of Iowa Health Care — Iowa City, Iowa (22.4 mi) · Sponsor: University of Alabama at Birmingham

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes N/A Observational 200 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi) · Sponsor: Jaeb Center for Health Research

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi) · Sponsor: Kura Oncology, Inc.

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi) · Sponsor: National Cancer Institute (NCI)

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

Fabry Disease N/A Observational 100 participants sought
University of Iowa Hospitals and Clinics — Iowa City, Iowa (22.4 mi) · Sponsor: Chiesi Farmaceutici S.p.A.

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi) · Sponsor: National Cancer Institute (NCI)

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

Hearing Loss, Unilateral, Deafness, Unilateral N/A Interventional 60 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi) · Sponsor: Cochlear
Actively enrolling

Studies you may be able to join near Cedar Rapids

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Cedar Rapids

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Cedar Valley Clinical Research, Waterloo, Iowa

4006 Johnathan St Ste. B, Waterloo, IA 50701
(319) 888-8270

Cedar Rapids Counseling Center

★ 4.5 (26 reviews)
373 Collins Rd NE, Cedar Rapids, IA 52402
(319) 320-7506
"It’s been years since I last went, but I have never found another therapist like Paige. As someone who (excuse my ego) thinks fast and does a lot of …"
— Ashley Jasunas, 5★

Clinical trials in Cedar Rapids: what's recruiting

The Cedar Rapids area currently has 595 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Cedar Rapids, the most active research areas are:

  • Cancer & Oncology17 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Cedar Rapids, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Cedar Rapids

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Cedar Rapids participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Cedar Rapids pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Cedar Rapids?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Cedar Rapids safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Cedar Rapids, IA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Paid clinical trials near Cedar Rapids

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts